YEAR
- 2015.03.05 Design and synthesis of biotin analogues reversibly binding with streptavidin. Yamamoto T, Aoki K, Sugiyama A, Doi H, Kodama T, Shimizu Y, Kanai M.Chem Asian J. 2015 Apr;10(4):1071-8. doi: 10.1002/asia.201500120
- 2015.02.25 The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma. Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T.BMC Cancer. 2015 Feb 25;15:82. doi: 10.1186/s12885-015-1065-8
- 2015.02.21 Molecular dynamics simulation-based evaluation of the binding free energies of computationally designed drug candidates: importance of the dynamical effects. Yamashita T, Ueda A, Mitsui T, Tomonaga A, Matsumoto S, Kodama T, Fujitani H.Chem. Pharm. Bull. 2014;62(7):661-7. doi: 10.1248/cpb.c14-00132
- 2015.02.10 RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer. Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Urano T, Takahashi S, Homma Y, Aburatani H, Inoue S.Oncotarget. 2015 Feb 10;6(4):2263-76. doi: 10.18632/oncotarget.2949
- 2015.02.05 A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. Nishii Y, Yamaguchi M, Kimura Y, Hasegawa T, Aburatani H, Uchida H, Hirata K, Sakuma Y.Int. J. Oncol. 2015 Apr;46(4):1781-7. doi: 10.3892/ijo.2015.2880
- 2015.02.02 Structure-based design of a streptavidin mutant specific for an artificial biotin analogue. Kawato T, Mizohata E, Shimizu Y, Meshizuka T, Yamamoto T, Takasu N, Matsuoka M, Matsumura H, Kodama T, Kanai M, Doi H, Inoue T, Sugiyama A.J. Biochem. 2015 Jun;157(6):467-75. doi: 10.1093/jb/mvv004
- 2015.01.13 Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses. Nakayama T, Mizohata E, Yamashita T, Nagatoishi S, Nakakido M, Iwanari H, Mochizuki Y, Kado Y, Yokota Y, Satoh R, Tsumoto K, Fujitani H, Kodama T, Hamakubo T, Inoue T.Protein Sci. 2015 Mar;24(3):328-40. doi: 10.1002/pro.2619
- 2015.01.03 Structure-based design and synthesis of a bivalent iminobiotin analog showing strong affinity toward a low immunogenic streptavidin mutant. Kawato T, Mizohata E, Shimizu Y, Meshizuka T, Yamamoto T, Takasu N, Matsuoka M, Matsumura H, Kodama T, Kanai M, Doi H, Inoue T, Sugiyama A.Biosci. Biotechnol. Biochem. 2015;79(4):640-2. doi: 10.1080/09168451.2014.991692
CLOSE